Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1981-08-28
1983-11-22
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
436548, 436536, 424 9, G01N 3300
Patent
active
044168667
ABSTRACT:
Antibodies and antigens are disclosed which provide a method of detecting and a method of combating flukes. Fluke infections are screened by determining presence of fluke antigens defined by antibodies produced by hybridomas ATCC HB-8086 and HB-8087. Chronic and acute fluke infections are distinguished by determining presence of fluke spine protein. Fluke infections are combated by injecting warm-blooded animals with antibodies produced by hybridomas ATCC HB-8086, HB-8087 and HB-8088, or with proteins defined by those antibodies.
REFERENCES:
Biological Abstracts, vol. 70(II), p. 7495, Abstract 71676, Verwaerde et al., (1980).
Proc. National Acad. Sci. USA, vol. 78(5), pp. 3165-3169, (1981), Mitchell et al.
Aust. J. Exp. Biol. Med. Sci., vol. 57, pp. 287-302 (1979), Mitchell et al.
C. R. Acad. Sc. Paris, t. 289 (Oct. 29, 1979), Serie D--725 (Translation Provided).
Moskowitz M.
Padgett Benjamin R.
The Johns Hopkins University
LandOfFree
Diagnosis and treatment of fluke infections with monoclonal anti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis and treatment of fluke infections with monoclonal anti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis and treatment of fluke infections with monoclonal anti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1814587